moxumbicRegenxbio (NASDAQ:RGNX) and Solid Biosciences (NASDAQ:SLDB) witnessed contrasting fortunes on Tuesday after Sarepta Therapeutics (NASDAQ:SRPT) disclosed a mortality linked to…
YinYangREGENXBIO (NASDAQ:RGNX) and Nippon Shinyaku have entered into a partnership for the development and commercialization of REGENXBIO’s gene therapies RGX-121…
